257 Situación actual en Inmunoterapia de Leishmaniasis. J. Convit,
P.L. Castellanos, M. Ulrich, A.J. Rondón, M.E. Pinardi, N. Rodríguez,
B. Infante, M. Gastes, S. Tellez, L. García y B. Bloom. Bol. Dermatol.
Sanit. 21: 42-56,1990.
258 Sinefungin as treatment for American Leishmania in sensitive
BALB/C and resistant C57B1/6 mices. Ávila, J.L., Rojas, T, Monzón,
H. and Convit,/. Amer. /. Trop. Med. Hyg. 43:139-145,1990.
259 Onchocerciasis. J. Convit and E. Rassi. Cap. en libro: Clinical
Tropical Dermatology. Ed. O. Canizarez & R. Harman, Bristol,
England, 1990.
260 Linfocitos T vírgenes y T memoria en la leishmaniasis cutánea
americana. A. Martínez-Arends, F.J. Tapia, G. Cáceres- Dittmar,
W. Mosca, L. Valecillos y J. Convit. Dermat. Venez. 28 (4): 125-127,1990.
261 Immunological suppression by human CD8 + T cells is receptor
dependent and HLA-DQrestricted. Sálgame, P, Convit, J. and Bloom,
B.R. Pmc. Nati. Acad. Sci. USA, 88: 2598-2602,1991.
262 Leprosy and Leishmaniasis Vaccines. J. Convit, M. Ulrich
and C. Sampson. Proceed. Symposium on Trop. Dis. and Vaccines.
Caracas, 1990, Third World Academy of Sciences, Trieste Italy. 1991.
263 IgM antibodies to native phenolic glicolipid I in contacts
of leprosy patients in Venezuela: Epidemiological observations and a prospective study of the risk of leprosy. Ulrich, M., Smith, P.C., Samp-son, C., Zúñiga, M., Centeno, M., García, V., Manrique, X., Salgado, A. & Convit, /. Int. J. Lepr. 59:405-415,1991.
264 Immunocytochemical characterization of immune cells in lesions
of American cutaneous leishmaniasis using novel T cell markers.
A. Martínez-Arends, F.J. Tapia, G. Cáceres-Dittmar, W. Mosca, L. Valecillos and J. Convit. Acta Trópica 49:271- 280,1991.
265 Differing Lymphokine Proflles of Functional Subsets of Human
CD4 and CD8 T-Cell Clones. Sálgame, P., Abrahams, J.S., Clayberger,
C., Goldstein, H., Convit, J., Modlin, R.L. and Bloom, B.R. Science,
254:279-282,1991.
266 Immunoprophylactic trial with combined Mycobacterium
leprae/BCG vaccine against leprosy: preliminary results. Convit,
J.. Sampson, C., Zúñiga, M., Smith, P.G., Plata, J., Silva, J., Molina,
J.. Pinardi,M.E., Bloom. B.R., Salgado, A. TheLancet,February 22,
pp.446-450,1992.
267 A major T cell antigen of Mycobacterium leprae is a lOkD heat-
shock cognate protein. V. Mehra, B.R. Bloom, A.C. Bajardi, C.L. Grisso,
P.A. Sieling, D. Alland, J. Convit, X. Fan, S.W. Hunter, P.J. Brennan,
T.H. Rea & R.L. Modlin. /. Exp. Med. 175: 275-284,1992.
268 Abendazole in the treatment of Onchocerciasis: double-blindR. Bartholomew, S. Núñez de Maza, S. Rodulfo, C.A. Welborn, M.L. Ebrhard &J. Convit. Am.J. Trop. Med. Hyg. 47:512-520,1992.
269 Parasitic oligosaocharide residues recognized by patients
with inucocutaneous and localized cutaneous leishmaniasis. J.L.
Ávila, M. Rojas and J. Convit. Am. J. Trop, Med. Hyg.
47 (3): 284-290,1992.
270 BCG vaccination protects against leprosy in Venezuela:
A case-control study. J. Convit, P.G. Smith, M. Zúñiga, C. Sampson, M. Ulrich, J. Plata, J. Silva, J. Molina and A. Salgado. Int. J. Lepr.
61 (2): 185-191,1993.
271 BCG vaccination protects against leprosy in Venezuela. J. Convit,
P.G. Smith, M. Zúñiga, C. Sampson, M. Ulrich, J.A. Plata, J. Silva,
J. Molina and A. Salgado. Proc. 14th Internat. Lepr. Congress,
p. 103,1993.
272 Leprosy in women: Clinical and immunological aspects.
Proc. 14th Internat. Lepr. Congress, p. 99,1993.
273 Determination of the cytokine proflle in American cutaneous
leishmaniasis using the polymerase chain reaction. G. Cáceres-Dittmar,
F.J. Tapia, M.A. Sánchez, M. Yamamura, K. Uyemura, R.L. Modlin,
B.R. Bloom & J. Convit. Clin. Exp. Immunol. 91: 500-505,1993.
274 The clinical and immunological spectrum of America cutaneous
leishmaniasis. J. Convit, M. Ulrich, C.T. Fernández, F.J. Tapia, G.
Cáceres-Dittmar, M. Gastes and A.J. Rondón. Trans. Roy. Soc. Trop.
Med. Hyg. 87: 444-448,1993.
275 Antigen-speciflc immunodeflciency and its relation to the spec¬
trum of American cutaneous leishmaniasis. J. Convit y M. Ulrich.
Biológica! Research 26(l): 159-166,1993.
276 Serum levéis of tumor necrosis factor in patients with American
cutaneous leishmaniasis. M. Gastes, D. Trujillo, M.E. Rojas, C.T.
Fernández, L. Araya, M. Cabrera, J. Blackwell, and J. Convit. Biol. Bes.
26:233-238,1993.
277 The cutaneous lesión in American leishmaniasis: leukocyte
subsets, cellular interaction and cytokine production. F.J. Tapia,
G. Cáceres-Dittmar, M.A. Sánchez, A.E. Fernández and J. Convit. Biol.
Res. 26: 239-247,1993.
278 Immunotherapy of leishmaniasis. A.J. Rondón and J. Convit.
En Dermatology: Progress and Perspectives, Edit. W.H.C. Burgdorf
and S.I. Katz (The Parthenon Publishing Group), pp 413-414,1993.
279 Adhesión molecules in lesions of American cutaneous leish¬
maniasis. F.J. Tapia, G. Cáceres-Dittmar, M.A. Sánchez, C.T. Fernández,
A.J. Rondón y J. Convit. Exp. DermatoL 3:17,22,1994.
280 Cutaneous leishmaniasis in Táchira State, Venezuela.
R. Maingon, D. Feliciangeli, B. Guzmán, N. Rodríguez, J. Convit, R. Adamson, M. Chance, I. Petralanda, M. Dougherty and R. Ward. Annals ofTrop. Med. andParasitol. 88 (l): 29-36,1994.
281 Analysis of vaccines preparad from armadillo-derived Myco-
bacterium leprae. Results of an inter-laboratory study co-ordinated
by the World Health Organization. Immunology of Mycobacterial
Diseases (IMMYC) Steering Committee, World Health Organization.
Int. ]. O/Lepr. 63 (l): 48-55,1995.
282 Visceral Leishmaniasis Due to a Leishmania Variant That Shares
Kinetoplast DNA Sequences with Leishmania braziliensis and Leish¬
mania mexicana in a Patient Infected with Human Immunodeflciency
Virus: Identification of the Leishmania Species with Use of the
Polymerase Chain Reaction. D. Hernández, N. Rodríguez, M.
Wessolossky and J. Convit. Clin. Infecí. Dis. 21: 701-702,1995.
283 Chapter 20 - Protozoan Diseases of the Skin - Leishmaniasis.
Convit, J. Lever's Histopathology of the Skin. 7th. Edition, 1996.
(Capítulo 20 - Enfermedades de la piel producidas por protozoarios-
Leishmaniasis. Lever - Histopatología de la piel). EN PRENSA.
284 Leishmaniasis. Immunological and clinical aspects and vaccines
in Venezuela. Convit, J. Clinical Dermatology. 1996. EN PRENSA.
285 Desarrollo de Inmunoterapia de la Leishmaniasis Cutánea
Americana en el Instituto de Biomedicina. Convit, J., Ulrich, M., Caste¬
llanos, P.L., Gastes M., Pinardi, M.E., De Lima, H., Zerpa, O., Hernández,
N., Herz, A. Gazeta Médica de Caracas. 1996. ENPRENSA.
286: Serologic response to mycobacterial proteins in hansen's patients during multidrug treatment. Int J Lepr Other Mycobact . Rada E, Aranzazu N, Ulrich M, Convit J. Dis. 1999 Dec;67(4):414-21. PubMed PMID: 10700916.
287 Aaby P, Babiker A, Darbyshire J, Nunn A, Barreto S, Alonso P, Badaro R,
Barros F, Victoria C, Binka F, Biryahwaho B, Byabamazima C, Sempala S, Tugume B,
Kalebu P, Kengeya-Kayondo J, Whitworth J, Paxton L, Convit J, Corrah T, McAdam K,
Datta M, Dowlati Y, Fine P, Tanner M, et al. Ethics of HIV trials. Lancet. 1997
Nov 22;350(9090):1546. PubMed PMID: 9388413.
288 Rada E, Ulrich M, Aranzazu N, Rodriguez V, Centeno M, Gonzalez I, Santaella
C, Rodriguez M, Convit J. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT). Int J Lepr Other Mycobact Dis. 1997 Sep;65(3):320-7. PubMed PMID: 9401484.
289 Rada EM, Aranzazu N, Convit J. Immunological reactions to mycobacterial proteins in the spectrum of leprosy. Int J Lepr Other Mycobact Dis. 1997 Dec;65(4):497-500. PubMed PMID: 9465162.
290 Rada-Schlaefli E, Santaella C, Aranzazu N, Convit J. Detection of antibodies toward secreted mycobacterial antigen 85 in untreated leprosy patients' sera. Int J Lepr Other Mycobact Dis. 1999 Jun;67(2):168-70. PubMed PMID: 10472373.
